Natasha Sheybani, an assistant professor at the University of Virginia, is collaborating with Children’s National Hospital to study a new treatment for pediatric brain cancer. Over two years, the team will combine chimeric antigen receptor (CAR) T-cell therapy, an immunotherapy, with low-intensity focused ultrasound to trigger an immune response in the brain. The project targets the “sonic hedgehog” and “group 3” subtypes of medulloblastoma, aiming to improve survival rates for these high-risk tumors, which often resist current treatments.
28 minutes ago
Leadership and management in ultrasound departments play a crucial role in shaping the efficiency and quality of patient care. An ultrasound department, like any other medical facility, requires not just […]
